Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Acute myeloid leukaemia

Recruiting

InvestigationalNo placebo

A study comparing venetoclax, azacitidine, and quizartinib versus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia patients not suitable for standard chemotherapy

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Quizartinib Dihydrochloride

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

Registered drugNo placebo

Study on Adding Darolutamide to First-Line Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer Using a Drug Combination

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cabazitaxel

Contact Research Centre

Bladder cancer

Recruiting

InvestigationalNo placebo

Study of EG-70 for Patients with Non-Muscle Invasive Bladder Cancer Unresponsive to BCG or High-Risk Patients New to BCG or with Incomplete BCG Treatment

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Lauromacrogol 400

Contact Research Centre

Cardiac failure acute

Recruiting

Registered drugNo placebo

Study on Using Furosemide and Hydrochlorothiazide for Treating Patients with Acute Heart Failure

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Furosemide

Contact Research Centre

Pulmonary embolism

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Oxygen

Contact Research Centre

Cervix carcinoma

Recruiting

Registered drugNo placebo

Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Ocular myasthenia

Not yet recruiting

Registered drugNo placebo

Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Rozanolixizumab

Contact Research Centre

Ocular myasthenia

Not yet recruiting

Registered drug

A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Rozanolixizumab

Contact Research Centre

Parkinson's disease

Not yet recruiting

Registered drug

A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Ioflupane (123I)

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drug

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Anti-neutrophil cytoplasmic antibody positive vasculitis

Not recruiting

Investigational

A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

Investigational

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

InvestigationalNo placebo

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Find therapies in clinical trials near you – page 2

38 trials match your criteria

Acute myeloid leukaemia

A study comparing venetoclax, azacitidine, and quizartinib versus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia patients not suitable for standard chemotherapy

Hormone-refractory prostate cancer

Study on Adding Darolutamide to First-Line Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer Using a Drug Combination

Bladder cancer

Study of EG-70 for Patients with Non-Muscle Invasive Bladder Cancer Unresponsive to BCG or High-Risk Patients New to BCG or with Incomplete BCG Treatment

Cardiac failure acute

Study on Using Furosemide and Hydrochlorothiazide for Treating Patients with Acute Heart Failure

Pulmonary embolism

Study on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism

Cervix carcinoma

Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

Ocular myasthenia

Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

Ocular myasthenia

A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

Parkinson's disease

A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease

Systemic lupus erythematosus

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Anti-neutrophil cytoplasmic antibody positive vasculitis

A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

Systemic lupus erythematosus

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.